Interface Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Interface (TILE)
The investigation follows a revenue miss and a delay in submitting the next-generation Zio MCT device to the Food and Drug Administration until 2027.
- On Friday, November 6, 2026, iRhythm Technologies, Inc. shares opened down more than 17% and fell more than 30% by midday after reporting third-quarter revenue of $221.6 million, missing the $222.2 million FactSet consensus estimate.
- Management reported flat year-over-year Zio AT sales and delayed the next-generation Zio MCT device submission to the FDA until 2027, citing portfolio integration efforts following the VitalConnect acquisition.
- During the November 5, 2026 earnings call, management said Zio AT revenue was "roughly flat compared to the prior year" and "below our expectations during the quarter."
- Levi & Korsinsky LLP launched an investigation into potential securities law violations, probing whether iRhythm Technologies made materially misleading statements regarding Zio products' performance and submission timelines.
- Investors who purchased IRTC stock and suffered financial losses may participate in the investigation, with eligibility based on purchase date and documented losses rather than current share ownership.
9 Articles
9 Articles
ashepostandtimes.com
Interface Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Interface (TILE)
Interface's new 2026 sales ceiling of $1.455 billion matches its prior floor, and TILE shares fell sharply after the change. An investigation is examining whether the Company's earlier sales outlook met its obligations under federal securities laws.
Daily Journal
BlackLine Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BlackLine (BL)
An investigation concerns BlackLine's exposure to SAP, after weaker SolEx channel expansion contributed to a reduced fiscal 2026 revenue outlook. A key SAP qualification for the Company's AI products is still pending.
IRTC Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into iRhythm Technologies, Inc. (IRTC)
A revenue shortfall against Wall Street consensus, flat Zio AT sales, and the Zio MCT FDA submission has now slipped into 2027. SueWallSt notifies investors of a pending investigation into potential securities law violations on behalf of investors who lost…
Coverage Details
Bias Distribution
- 72% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
